Research Topics
Genomes and Genes
| CPB2SummaryGene Symbol: CPB2 Description: carboxypeptidase B2 (plasma) Alias: CPU, PCPB, TAFI, carboxypeptidase B-like protein, carboxypeptidase B2, carboxypeptidase B2 (plasma, carboxypeptidase U), carboxypeptidase U, plasma carboxypeptidase B, thrombin-activable fibrinolysis inhibitor, thrombin-activatable fibrinolysis inhibitor Species: human Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patientsI Fernandez-Cadenas
Neurovascular Research Laboratory, Neurovascular Unit, Department of Neurology of Vall d Hebron University Hospital, Universitat Autonoma de Barcelona, Vall d Hebron University Hospital, Barcelona, Spain
J Thromb Haemost 5:1862-8. 2007..Thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 (PAI-1) are fibrinolysis inhibitors...
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1Mirjam E Meltzer
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
Blood 116:113-21. 2010..levels were the main determinants of CLT, followed by plasminogen, thrombin-activatable fibrinolysis inhibitor (TAFI), prothrombin, and alpha2-antiplasmin. Fibrinogen, factor VII, X, and XI contributed minimally...
Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidaseZuzana Valnickova
Center for Insoluble Protein Structure at the Department of Molecular Biology, Science Park, University of Aarhus, Gustav Wieds Vej 10C, 8000 Aarhus C, Denmark
J Biol Chem 282:3066-76. 2007Thrombin-activable fibrinolysis inhibitor (TAFI) is a carboxypeptidase found in human plasma, presumably as an inactive zymogen...
The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIaKanchan Anand
Sanofi Aventis Pharma Deutschland GmbH, Industriepark Hochst, 65926 Frankfurt am Main, Germany
J Biol Chem 283:29416-23. 2008..In accordance with its in vitro antifibrinolytic activity, animal studies have reported that inhibition of mature TAFI aids in the prevention of thrombosis...
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuriaYutaka Yano
Third Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514 8507, Japan
J Clin Endocrinol Metab 88:736-41. 2003..Recently, a new potent inhibitor of fibrinolysis, the thrombin-activatable fibrinolysis inhibitor (TAFI), has been isolated from human plasma...
Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysisLaura Sanglas
Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i Biologia Molecular Facultat de Ciències, Universitat Autonoma de Barcelona, E 08193 Bellaterra, Spain
Mol Cell 31:598-606. 2008Thrombin-activatable fibrinolysis inhibitor (TAFI) is a metallocarboxypeptidase (MCP) that links blood coagulation and fibrinolysis. TAFI hampers fibrin-clot lysis and is a pharmacological target for the treatment of thrombotic conditions...
Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patientsOsamu Hataji
Third Department of Internal Medicine, Respiratory Division, Mie University School of Medicine, Edobashi 2 174, Tsu City, Mie 514 8507, Japan
Am J Hematol 76:214-9. 2004..This study suggests that thrombin-activatable fibrinolysis inhibitor, in part secreted from lung cancer cells, may play a role in the pathogenesis of thrombotic disorders in lung cancer patients...
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase NWilliam D Campbell
Choju Medical Institute, Fukushimura Hospital, Toyohashi, Aichi, Japan
Microbiol Immunol 46:131-4. 2002..also known as thrombin-activatable fibrinolysis inhibitor (TAFI), precursor of carboxypeptidase U and plasma carboxypeptidase B is present in plasma and following activation by thrombin/thrombomodulin and/or plasmin can remove ..
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibYoshimasa Aso
Department of Internal Medicine, Koshigaya Hospital, Dokkyo University School of Medicine, 2 1 50 Minami Koshigaya, Koshiagya, Saitama 343 8555, Japan
Diabetes Care 28:2211-6. 2005To determine whether plasma concentrations of thrombin-activatable fibrinolysis inhibitor (TAFI) in patients with type 2 diabetes were associated with components of metabolic syndrome (MS), including high-sensitivity C-reactive protein (..
Post-translational modifications of human thrombin-activatable fibrinolysis inhibitor (TAFI): evidence for a large shift in the isoelectric point and reduced solubility upon activationZuzana Valnickova
Center for Insoluble Protein Structure inSPIN at the Department of Molecular Biology, Science Park, University of Aarhus, Gustav Wied s Vej 10C, 8000 Aarhus C, Denmark
Biochemistry 45:1525-35. 2006Thrombin-activable fibrinolysis inhibitor (TAFI) is distinct from pancreatic procarboxypeptidase B in several ways. The enzymatic activity of TAFIa is unstable and decays with a half-life of a few minutes...
Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysisWolfgang Knecht
AstraZeneca R and D Molndal, Molndal, Sweden
FEBS J 273:778-92. 2006Procarboxypeptidase U [proCPU, thrombin-activatable fibrinolysis inhibitor (TAFI), EC 3.4.17.20] belongs to the metallocarboxypeptidase family and is a zymogen found in human plasma...
A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal diseaseJ A Kremer Hovinga
Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Thromb Haemost 2:54-7. 2004..Recently, TAFI (thrombin-activatable fibrinolysis inhibitor) was identified as a link between coagulation and fibrinolysis, as ..
Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavageP F Marx
Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center, P O Box 85500, 3508 GA Utrecht, The Netherlands
J Biol Chem 275:12410-5. 2000Thrombin-activable fibrinolysis inhibitor (TAFI) is present in the circulation as an inactive zymogen...
TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME StudyP E Morange
INSERM U626, Hematology Laboratory, Faculty of Medicine, CHU Timone, Marseille, France
J Thromb Haemost 3:1503-10. 2005To evaluate the association of thrombin-activatable fibrinolysis inhibitor (TAFI) gene polymorphisms with the risk of coronary heart disease (CHD) and with TAFI levels measured by a newly developed enzyme-linked immunosorbent assay (ELISA)..
Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasmaD L Eaton
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080
J Biol Chem 266:21833-8. 1991..We propose that the Mr 60,000 plasminogen-binding protein isolated here is a novel human plasma carboxypeptidase B and that it be designated pCPB.
TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clotsN J Mutch
Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
J Thromb Haemost 5:812-7. 2007..b>Thrombin activatable fibrinolysis inhibitor (TAFI), a plasma procarboxypeptidase activated by thrombin-thrombomodulin to form TAFIa, also ..
Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone proteinZ Valnickova
Duke University Medical Center, Department of Pathology, Durham, North Carolina 27710, USA
J Biol Chem 271:12937-43. 1996..The specific binding of plasma CPB to alpha-macroglobulins suggest that these proteins may function as a "shuttle" in vivo to modulate the clearance of plasma CPB from the circulatory system...
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complexL Bajzar
Department of Biochemistry, Queen s University, Kingston, Ontario K7L 3N6, Canada
J Biol Chem 271:16603-8. 1996b>TAFI (thrombin-activatable fibrinolysis inhibitor) is a recently discovered plasma protein that can be activated by thrombin-catalyzed proteolysis to a carboxypeptidase B-like enzyme that inhibits fibrinolysis...
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammationTimothy Myles
Division of Hematology, Department of Medicine, Stanford University School of Medicine, California 94305, USA
J Biol Chem 278:51059-67. 2003The latent plasma carboxypeptidase thrombin-activable fibrinolysis inhibitor (TAFI) is activated by thrombin/thrombomodulin on the endothelial cell surface, and functions in dampening fibrinolysis...
Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stabilityE Ceresa
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
J Thromb Haemost 5:2105-12. 2007Activated thrombin activatable fibrinolysis inhibitor (TAFIa) plays a pivotal role in fibrinolysis. TAFIa activity is regulated by a temperature-dependent instability...
Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulationPauline F Marx
Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Blood 112:2803-9. 2008Thrombin-activatable fibrinolysis inhibitor (TAFI) is a pro-metallocarboxypeptidase that can be proteolytically activated (TAFIa)...
Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoformsL Zhao
Department of Cardiovascular Research, Berlex Biosciences, Richmond, California 94804, USA
Thromb Haemost 80:949-55. 1998Thrombin-activatable fibrinolysis inhibitor (TAFI) is synthesized by the liver and is thought to circulate in plasma as a plasminogen-bound zymogen...
Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitorKarlien Buelens
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Campus Gasthuisberg, O and N2, PB 824, Herestraat 49, B 3000 Leuven, Belgium
Circ Res 102:295-301. 2008Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) exerts an antifibrinolytic effect by removing C-terminal lysines from partially degraded fibrin...
Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formationB N Bouma
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
Thromb Haemost 82:1703-8. 1999b>Thrombin Activatable Fibrinolysis Inhibitor (TAFI) also known as plasma procarboxypeptidase B is activated by relatively high concentrations of thrombin in a reaction stimulated by thrombomodulin...
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levelsC Erem
Karadeniz Technical University Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Trabzon, Turkey
J Endocrinol Invest 32:169-74. 2009..To our knowledge, plasma tissue factor pathway inhibitor (TFPI) and thrombin-activatable fibrinolysis inhibitor (TAFI) levels in these patients have not been investigated...
Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitorP F Marx
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
J Thromb Haemost 3:1293-300. 2005Thrombin-activatable fibrinolysis inhibitor (TAFI) is a procarboxypeptidase that, once activated, can attenuate fibrinolysis. The active form, TAFIa, is a labile enzyme, with a half-life of a few minutes at 37 degrees C...
Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulationTaro Taketomi
Division of Cardiothoracic Anesthesia, Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA
Blood Coagul Fibrinolysis 19:135-41. 2008..Sustained thrombin generation also activates thrombin-activatable fibrinolysis inhibitor (TAFI), which stabilizes fibrin clot against fibrinolysis...
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptivesJ C Meijers
Department of Haematology, University Medical Center Utrecht, The Netherlands
Thromb Haemost 84:9-14. 2000..These OC-induced changes were not different between the two contraceptive pills. TAFI (thrombin-activatable fibrinolysis inhibitor) levels increased on levonorgestrel, and even further increased on ..
Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia AJ Antovic
Coagulation Research, Department of Surgical Sciences, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
Haemophilia 7:557-60. 2001..It can be catalysed into its active form, TAFI (TAFIa, carboxypeptidase U or B) by a complex of thrombin/thrombomodulin...
Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIIIVance G Nielsen
Department of Anesthesiology, University of Alabama at Birmingham, 619 South 19th Street, Birmingham, AL 35249 6810, USA
J Heart Lung Transplant 25:1247-52. 2006..However, contact activation and Factor XI have enhanced thrombin-activatable fibrinolysis inhibitor (TAFI) activation and decreased fibrinolysis, and Factor XIII (FXIII) also delays fibrinolysis via alpha(2)-anti-plasmin ..
[Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients]Izabela Kemona-Chetnik
Klinika Alergologii i Chorob Wewnetrznych, Akademii Medycznej w Białymstoku
Przegl Lek 63:1281-5. 2006Increased thrombin generation occurs in the airways of asthmatic patients. Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme which after activation by a thrombin-thrombomodulin complex inhibits ..
Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase BKokichi Suzuki
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd, Yokohama, Japan
J Pharmacol Exp Ther 309:607-15. 2004Plasma procarboxypeptidase B, also known as thrombin-activatable fibrinolysis inhibitor (TAFI), is converted by thrombin into the active enzyme, carboxypeptidase B (CPB)/activated TAFI...
Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparinsFabrizio Semeraro
Department of Biomedical Sciences and Human Oncology, Section of General and Experimental Pathology, University of Bari, Bari, Italy
Haematologica 94:819-26. 2009Thrombin is the main activator of the fibrinolysis inhibitor TAFI (thrombin activatable fibrinolysis inhibitor) and heightened clotting activation is believed to impair fibrinolysis through the increase of thrombin activatable ..
A comprehensive study on hemostasis in CAPD patients treated with erythropoietinJolanta Malyszko
Department of Nephrology and Internal Medicine, Bialystok University School of Medicine, Bialystok, Poland
Perit Dial Int 22:582-92. 2002..b>Thrombin activatable fibrinolysis inhibitor (TAFI) is a key protein linking coagulation and fibrinolysis...
Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathwaysA K So
Service of Rheumatology, University Hospital of Lausanne, Lausanne, Switzerland
J Thromb Haemost 1:2510-5. 2003..Objective: To determine the extent of activation of the coagulation and fibrinolytic pathways in different joint diseases in humans and to ascertain the factors that may influence fibrin deposition within the joint...
[The TAFI system. The new role of fibrinolysis]C E Dempfle
Universitatsklinikum Mannheim, I Medizinische Klinik, Theodor Kutzer Ufer 1 3, 68167 Mannheim
Hamostaseologie 27:278-81. 2007..The thrombin-activated fibrinolysis inhibitor (TAFI) is an important regulator of fibrinolysis...
Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel diseaseIoannis E Koutroubakis
Department of Gastroenterology, University Hospital Heraklion, Heraklion, Crete, Greece
Eur J Gastroenterol Hepatol 20:912-6. 2008..As plasminogen activator inhibitor-1 (PAI-1) and thrombin-activatable fibrinolysis inhibitor (TAFI) are inhibitors of fibrinolysis, we studied TAFI as well as PAI-1 plasma levels in IBD patients compared with ..
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulinL O Mosnier
Dept of Haematology, University Medical Center, Utrecht, The Netherlands
Thromb Haemost 85:5-11. 2001b>Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme, that after activation down regulates fibrinolysis. TAFI is activated by thrombin in the presence of the cofactor thrombomodulin (TM)...
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitorPauline F Marx
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands
J Biol Chem 279:6620-8. 2004..TAFIa is a labile enzyme that can be inactivated by conformational instability or proteolysis. TAFI is approximately 40% identical to pancreatic carboxypeptidase B (CPB)...
Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabodyJ Develter
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
J Thromb Haemost 6:1884-91. 2008b>Thrombin activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 (PAI-1) play important roles in fibrinolysis. Both reduce plasmin generation, but they exert their antifibrinolytic effects via different mechanisms...
Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidismCihangir Erem
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey
Eur J Endocrinol 160:863-8. 2009..To our knowledge, plasma tissue factor pathway inhibitor (TFPI) and thrombin-activatable fibrinolysis inhibitor (TAFI) levels in these patints have not been investigated...
Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levelsA Santamaria
Department of Hematology, Hospital de la Santa Creu i Sant Pau, C Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain
Stroke 34:2387-91. 2003Recently, a novel procarboxypeptidase B-like proenzyme, called thrombin-activatable fibrinolysis inhibitor (TAFI), has been described. It plays an important role in the delicate balance between coagulation and fibrinolysis...
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)B N Bouma
Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center, Utrecht, The Netherlands
J Thromb Haemost 1:1566-74. 2003..was described, which downregulated fibrinolysis after it was activated by thrombin, and was therefore named TAFI (thrombin-activatable fibrinolysis inhibitor; EC 3.4.17.20)...
Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunctionCheng Hock Toh
Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, UK
Blood Coagul Fibrinolysis 14:S69-71. 2003b>Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme, which is synthesized in the liver and circulates in the blood at a concentration of about 275 nmol/l...
Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysisLaszlo Bajzar
McMaster University, Hamilton, Ontario, Canada
Crit Care Med 32:S320-4. 2004To review the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and activity of activated TAFI (TAFIa) as it relates to the regulation of both fibrinolytic and proinflammatory substances.
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidismCihangir Erem
Division of Endocrinology and Metabolism, Department of Internal Medicine, Karadeniz Technical University Faculty of Medicine, K T Ü Tıp Fakültesi, Ic Hastaliklari Anabilim Dali, 61080 Trabzon, Turkey
Endocrine 36:473-8. 2009..The levels of plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and tissue factor pathway inhibitor (TFPI) have been very rarely investigated in patients with ..
The profibrinolytic effect of plasma thrombomodulin in factor XI deficiency and its implications in hemostasisL Dai
The Haemophilia Reference Center, Center for Haemostasis and Thrombosis, St Thomas Hospital, London, UK
J Thromb Haemost 2:2200-4. 2004..tendency in factor (F)XI deficiency may result from premature clot lysis due to insufficient thrombin activatable fibrinolysis inhibitor (TAFI) activation...
Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombinLaurent O Mosnier
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA
J Biol Chem 286:502-10. 2011..TM) is a cofactor for thrombin-mediated activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI) and thereby helps coordinate coagulation, anticoagulation, fibrinolysis, and inflammation...
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIIIJ P Antovic
Coagulation Research, Department of Surgical Sciences, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
Haemophilia 8:781-6. 2002..and/or inhibitors to factor VIII/IX could enhance generation of thrombin-activatable fibrinolysis inhibitor (TAFI), a recently described link between coagulation and fibrinolysis...
Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathyJolanta Małyszko
Department of Nephrology and Transplantology, Medical University, 15 540 Białystok Zurawia 14, Poland
Thromb Haemost 91:480-6. 2004..It has been postulated that TAFI-thrombin activatable fibrinolysis inhibitor, which couples two opposite systems: coagulation and fibrinolysis, may be involved in the ..
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assayJovan P Antovic
Coagulation Research, Department of Surgical Sciences, Karolinska Hospital, Stockholm, Sweden
Thromb Haemost 90:620-7. 2003..the effects of different concentrations of recombinant factor VIIa on overall hemostasis and on thrombin activatable fibrinolysis inhibitor (TAFI) dependent fibrinolysis in different factor deficient plasmas...
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertensionJolanta Małyszko
Department of Nephrology and Transplantology, Medical University, Białystok, Poland
Pol Arch Med Wewn 118:36-41. 2008Hypertension is associated with hemostatic abnormalities and endothelial dysfunction. thrombin activatable fibrinolysis inhibitor (TAFI) is a glycoprotein linking coagulation and fibrinolysis. Objectives...
Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIIIVance G Nielsen
Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, Alabama 35249 6810, USA
Blood Coagul Fibrinolysis 19:793-800. 2008..Direct thrombin inhibitors and heparin enhance fibrinolysis by inhibition of activation of thrombin activatable fibrinolysis inhibitor (TAFI); however, the role played by other thrombin-activated proteins [e.g...
[Study of fibrinolysis inhibitors in 117 acute leukemia patients]Wen Wang
Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
Zhonghua Xue Ye Xue Za Zhi 29:183-6. 2008To explore the clinical significance of fibrinolysis inhibitors including thrombin activatable fibrinolysis inhibitor(TAFI), plasminogen activator inhibitor (PAI) and alpha2-plasmin inhibitor (alpha2-PI) in acute leukemia (AL).
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole bloodC Carrieri
Department of Biomedical Sciences and Human Oncology, Section of General and Experimental Pathology, Aldo Moro University, Bari, Italy
J Thromb Haemost 9:154-62. 2011..The role of TAFI in platelet-mediated resistance to lysis is unclear...
Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidismNilay Ermantas
Internal Medicine, Medical Faculty, Trakya University, Edirne, Turkey
Clin Appl Thromb Hemost 16:568-73. 2010..It was recently shown that thrombin-activatable fibrinolysis inhibitor (TAFI) attenuates fibrinolysis and also fibrin-plasminogen interaction by the removal of lysine and arginine residues ..
TAFI and PAI-1 levels in human sepsisSacha Zeerleder
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern, Switzerland
Thromb Res 118:205-12. 2006Plasminogen activator inhibitor type-1 (PAI-1) is considered to be the main inhibitor of fibrinolysis in sepsis. However, the contribution of TAFI to the inhibition of fibrinolysis in sepsis is currently unknown.
Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemiaGalila M Mokhtar
Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Pediatr Hematol Oncol 27:363-73. 2010Profound hemostatic changes have been observed among thalassemic patients. Thrombin activatable fibrinolysis inhibitor (TAFI) is a newly discovered protein that potentially attenuates fibrinolysis...
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survivalPaolo Gresele
Department of Internal Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, Via E dal Pozzo, 06126 Perugia, Italy
Thromb Res 121:763-8. 2008b>TAFI (thrombin-activatable fibrinolysis inhibitor) is a potent anti-fibrinolytic and anti-inflammatory factor of liver origin...
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitorC T Ammollo
Department of Biomedical Sciences and Human Oncology, Section of General and Experimental Pathology, University of Bari, Bari, Italy
J Thromb Haemost 8:790-8. 2010..counteracting the antifibrinolytic effects of thrombin, which include thrombin-activatable fibrinolysis inhibitor (TAFI) activation and clot structure enhancement...
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysisT Lisman
Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center, 3508 GA Utrecht, The Netherlands
Gastroenterology 121:131-9. 2001..In this study, the role of the recently discovered inhibitor of fibrinolysis, thrombin-activatable fibrinolysis inhibitor (TAFI) in cirrhosis was examined.
Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulationL O Mosnier
Dept of Haematology, University Hospital, Utrecht, The Netherlands
Thromb Haemost 80:829-35. 1998b>Thrombin Activatable Fibrinolysis Inhibitor (TAFI) is a recently identified fibrinolysis inhibitor in plasma, that when converted to an enzyme potently attenuates fibrinolysis...
Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activatorMarc Ribo
Neurovascular Research Laboratory, Neurovascular Unit Hospital Vall d Hebron, Barcelona, Spain
Stroke 35:2123-7. 2004..We aim to determine the predictive value of pretreatment levels of fibrinolysis inhibitors (PAI-1, lipoprotein(a), TAFI, and homocysteine) on SICH.
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia ATon Lisman
Thrombosis and Haemostasis Laboratory, Department of Haematology, Institute of Biomembranes, Van Creveldkliniek, University Medical Centre, Utrecht University, The Netherlands
Blood 99:175-9. 2002..not only a disorder of coagulation, but that hyperfibrinolysis due to a defective activation of thrombin activatable fibrinolysis inhibitor (TAFI) might also play a role...
Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungsChengliang Wu
Berlex Biosciences, Department of Pharmacology, P O Box 4099, 2600 Hilltop Drive, Richmond, A 94804 0099, USA
Thromb Haemost 90:414-21. 2003Studies have shown that inhibition of TAFI by small peptides enhances pharmacological effects of tPA in animal models of thrombosis, suggesting that TAFI modulates the fibrinolytic system...
Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazoneSerkan Yener
Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey
Med Princ Pract 18:266-71. 2009..To evaluate subclinical inflammation and fibrinolysis in low-risk type 2 diabetic subjects and to assess the efficacy of metformin and rosiglitazone in this group...
Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patientsJolanta Małyszko
Department of Nephrology, Medical University, Białystok, Poland
Med Sci Monit 15:CR644-9. 2009..Thrombin-activatable fibrinolysis inhibitor (TAFI) is a recently discovered inhibitor of the fibrinolytic system...
High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic strokeF W G Leebeek
Department of Hematology, Erasmus University Medical Center, Rotterdam
J Thromb Haemost 3:2211-8. 2005Several studies have suggested that thrombin-activatable fibrinolysis inhibitor (TAFI) levels are associated with the risk of arterial thrombosis, but results have been contradictory...
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC studyE L E de Bruijne
Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
J Thromb Haemost 7:919-27. 2009b>Thrombin activatable fibrinolysis inhibitor (TAFI) attenuates fibrinolysis and may therefore contribute to the pathophysiology of arterial thrombosis...
Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in miceRosemarijn Renckens
Laboratory of Experimental Internal Medicine, Amsterdam, The Netherlands
J Immunol 175:6764-71. 2005Thrombin-activatable fibrinolysis inhibitor (TAFI), also known as carboxypeptidase R, has been implicated as an important negative regulator of the fibrinolytic system...
Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacementBaris Akinci
Dokuz Eylul University Medical School, Department of Internal Medicine, Division of Endocrinology and Metabolism, Izmir, Turkey
Endocr J 54:45-52. 2007..b>Thrombin activatable fibrinolysis inhibitor (TAFI) is an inhibitor of fibrinolysis, which has been recently isolated from human plasma...
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PAM Colucci
Department of Biomedical Sciences, University of Bari, Italy
Thromb Haemost 85:661-6. 2001TAFI (thrombin activatable fibrinolysis inhibitor) is a plasma procarboxypeptidase that upon activation inhibits the fibrinolytic process by removing the C-terminal lysines from partially degraded fibrin...
Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human plateletsS L Schadinger
Department of Biochemistry, Queen s University, Kingston, ON, Canada
J Thromb Haemost 8:2523-9. 2010The thrombin-activatable fibrinolysis inhibitor (TAFI) is a zymogen first characterized in human plasma that is activated through proteolytic cleavage by thrombin, thrombin in complex with thrombomodulin, or plasmin...
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factorsI Juhan-Vague
Laboratory of Hematology, Centre de Détection et de Prévention de l Athérosclérose, CHU Timone, Marseille, France
Arterioscler Thromb Vasc Biol 20:2156-61. 2000Thrombin-activatable fibrinolysis inhibitor (TAFI) is a recently described fibrinolysis inhibitor that circulates in plasma as a procarboxypeptidase and is converted into an active form during coagulation...
Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemiaJ C Meijers
The Department of Haematology, University Medical Centre, Utrecht, The Netherlands
Br J Haematol 108:518-23. 2000..Several processes are involved, such as disseminated intravascular coagulation and hyperfibrinolysis. Recently, TAFI (thrombin-activatable fibrinolysis inhibitor) was identified as a link between coagulation and fibrinolysis...
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complicationsJovan P Antovic
Department of Surgical Sciences, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden Jovan
Blood Coagul Fibrinolysis 14:551-6. 2003We investigated thrombin activatable fibrinolysis inhibitor (TAFI) and its influence on fibrinolysis by measuring pro-TAFI activity and total TAFI antigen in 38 patients with type I diabetes mellitus (18 with and 20 without microvascular ..
The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?P F Marx
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
J Thromb Haemost 7:445-52. 2009Thrombin-activatable fibrinolysis inhibitor (TAFI) is a 56-kDa procarboxypeptidase...
Discovery of novel mechanisms and molecular targets for the inhibition of activated thrombin activatable fibrinolysis inhibitorK Hillmayer
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven
J Thromb Haemost 6:1892-9. 2008b>Thrombin activatable fibrinolysis inhibitor (TAFI) is an important regulator of fibrinolysis and an attractive target to develop profibrinolytic drugs.
Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?Bonno N Bouma
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA
Ann Med 38:378-88. 2006..it not only forms the clot but it is also involved in stabilizing the clot by activating thrombin activatable fibrinolysis inhibitor (TAFI). Activated TAFI protects the fibrin clot against lysis...
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitorJan Develter
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium
Thromb Haemost 102:69-75. 2009b>Thrombin activatable fibrinolysis inhibitor (TAFI) attenuates fibrinolysis and is considered as an attractive drug target...
Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological rolesMichael B Boffa
Department of Biochemistry, Queen s University, Kingston, Ontario, Canada K7L 3N6
Clin Biochem 40:431-42. 2007The thrombin-activatable fibrinolysis inhibitor (TAFI) pathway defines a novel molecular connection between blood coagulation and both fibrinolysis and inflammation...
Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patientsJolanta Małyszko
Department of Nephrology and Transplantology, Medical University, Białystok, Poland
Am J Nephrol 24:624-9. 2004b>Thrombin activatable fibrinolysis inhibitor (TAFI) is a regulator of endogenous fibrinolysis...
Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activityM D Phaneuf
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Artif Organs 22:657-65. 1998..This BSA-SMCC complex was then covalently linked to the carboxylated polyurethane (cPU) surface via the crosslinker EDU (cPU-BSA-SMCC)...
Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinolineH Dong
Department of Physiology, Faculty of Medicine, University of Hong Kong
Br J Pharmacol 109:113-9. 19931. The effects of CPU-23 (1-(1-[(6-methoxyl)-naphth-2-yl])-propyl-2-(1-piperidine)-acetyl-6 ,7- dimethyoxy-1,2,3,4-tetra-hydroisoquinoline) were studied on mechanical and electrical activities, and intracellular free calcium ([Ca2+]i) of ..
Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamineT Nikaido
Department of Pharmacology and Brain Science, School of Human Sciences, Waseda University, Tokorozawa, Saitama, Japan
Mol Pharmacol 59:894-900. 2001..Although the caudate/putamen (CPu) expresses mPer1 and/or mPer2 mRNA, the function of these genes in this nucleus has not yet been elucidated...
A comparison between automatically generated linear and parabolic tetrahedra when used to mesh a human femurK Polgar
Oxford Orthopaedic Engineering Centre, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7LD, UK
Proc Inst Mech Eng H 215:85-94. 2001..were compared with four-node linear tetrahedron elements (T4) on the basis of accuracy and central processing unit (CPU) time...
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicityDavid M Thomas
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA
J Neurochem 109:1745-55. 2009..The brain structure most affected by METH is the caudate-putamen (CPu) where long-term DA depletion and microglial activation are most evident...
Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndromeMika Skeppholm
Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiology, SE 182 88 Stockholm, Sweden
Thromb Res 121:175-81. 2007b>TAFI was measured as relative activity concentration (Pefakit) and antigen concentration (Haemochrom and Asserachrom) both acutely and during convalescence in patients suffering from acute coronary syndrome, and in a group of healthy ..
Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosisN E Bruno
Department of Diabetes and Endocrinology, Mie University Graduate School of Medicine, Tsu City, Mie, Japan
J Thromb Haemost 6:139-46. 2008Thrombin-activatable fibrinolysis inhibitor (TAFI) has been reported to affect wound healing and fibrotic processes, but its role in renal tubulointerstitial fibrosis remains unknown.
Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitorVance G Nielsen
Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, Alabama 35249 6810, USA
Blood Coagul Fibrinolysis 19:283-7. 2008..This study proposed to kinetically define fibrinolytic vulnerability and the contribution of thrombin activatable fibrinolysis inhibitor to fibrinolytic defenses in normal subjects...
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?J L Willemse
Laboratory of Medical Biochemistry, University of Antwerp, Antwerp, Belgium
J Thromb Haemost 7:1962-71. 2009..The development of carboxypeptidase U (CPU) inhibitors as profibrinolytic agents is an attractive concept and possibilities for rational drug ..
Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitorJ H Foley
Department of Biochemistry, Queen s University, Kingston, ON, Canada
J Thromb Haemost 7:453-9. 2009..in plasmas deficient in components of the intrinsic pathway, due to a failure to activate thrombin activatable fibrinolysis inhibitor (TAFI)...
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiencyNelson E Bruno
Department of Immunology, Mie University Graduate School of Medicine, Edobashi 2 174, Tsu City, 514 8507 Mie, Japan
Thromb Haemost 100:90-100. 2008..Thrombin-activatable fibrinolysis inhibitor (TAFI) is a potent inhibitor of plasmin generation...
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndromeErtan Adali
Department of Obstetrics and Gynecology, Yuzuncu Yil University, Van, Turkey
Fertil Steril 94:666-72. 2010....
Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in ratsHitesh Soni
Zydus Research Centre, Ahmedabad, India
Pharmacology 82:304-9. 2008Thrombin-activatable fibrinolysis inhibitor (TAFI) is a basic carboxypeptidase zymogen that can be activated by thrombin...
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasmaK Hillmayer
Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
J Thromb Haemost 6:132-8. 2008Altered plasma levels of thrombin activatable fibrinolysis inhibitor (TAFI) are associated with a large number of pathologies...
Symptoms of problematic cellular phone use, functional impairment and its association with depression among adolescents in Southern TaiwanCheng Fang Yen
Department of Psychiatry, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
J Adolesc 32:863-73. 2009The aims of this study were: (1) to examine the prevalence of symptoms of problematic cellular phone use (CPU); (2) to examine the associations between the symptoms of problematic CPU, functional impairment caused by CPU and the ..
Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhagesValeria Matus
Department of Haematology Oncology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile
Clin Chim Acta 401:158-61. 2009..Theoretically, decreased plasma procarboxypeptidase U (proCPU) levels or lower carboxypeptidase U (CPU) stability would result in higher fibrinolytic activity and bleeding tendency.
The bone tissue responses to prehydrated and collagenated cortico-cancellous porcine bone grafts: a study in rabbit maxillary defectsUlf Nannmark
Institute of Biomedicine, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
Clin Implant Dent Relat Res 10:264-70. 2008..Adding collagen gel to prehydrated and collagenated porcine bone (PCPB) particles results in a sticky and moldable material which facilitates clinical handling...
Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosisHajime Fujimoto
Institute of Clinical Medicine and Biomedical Sciences, Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Edobashi 2 174, Tsu City, Mie 514 8507, Japan
Am J Pathol 168:1086-96. 2006..Thrombin-activatable fibrinolysis inhibitor (TAFI) is a strong suppressor of fibrinolysis, but its role in lung fibrosis is unknown...
Evidence for natural horizontal transfer of the pcpB gene in the evolution of polychlorophenol-degrading sphingomonadsMarja A Tiirola
Department of Biological and Environmental Science, FIN 400014 University of Jyväskylä, Finland
Appl Environ Microbiol 68:4495-501. 2002The chlorophenol degradation pathway in Sphingobium chlorophenolicum is initiated by the pcpB gene product, pentachlorophenol-4-monooxygenase...
Research Grants
- Factor Xl in Vascular ThrombosisDavid Gailani; Fiscal Year: 2010..to fibrin formation, fXIa promotes clot resistance to fibrinolysis in a process involving the proteinase TAFI. Several lines of evidence indicate fXIa contributes to pathologic coagulation...
- Factor Xl in Vascular ThrombosisDavid Gailani; Fiscal Year: 2007..to fibrin formation, fXIa promotes clot resistance to fibrinolysis in a process involving the proteinase TAFI. Several lines of evidence indicate fXIa contributes to pathologic coagulation...
- Carboxypeptidases in Thrombosis and InflammationLaszlo Bajzar; Fiscal Year: 2007..The two CP, activated TAFI (TAFla) and carboxypeptidase N (CPN) both remove C-terminal lysine and arginine residues from protein substrates...
- STRUCTURAL STUDIES OF BLOOD CLOTTING PROTEINSJOHN WEISEL; Fiscal Year: 2004..enzyme/activator and the mode of its introduction, and the presence of other proteins, such as Lp(a), PAI-1, and TAFI. One of the principal approaches will be to follow digestion in real time using confocal microscopy in both ..
- CLASSICAL AND ALTERNATIVE PATHWAYS OF FIBRINOLYSISEdward Plow; Fiscal Year: 2005..are apo(a), which is composed of multiple kringles, including ones with LBS activity, and plasma carboxypeptidaseB, TAFI, which removes the C-terminal lysines from degrading fibrin and cell surfaces...
- CLASSICAL AND ALTERNATIVE PATHWAYS OF FIBRINOLYSISEDWARD FRANKLIN PLOW; Fiscal Year: 2010..In addition, modulators of the LBS of plasminogen, apoprotein(a) and TAFI, occur naturally and their influence on plasminogen-dependent inflammatory responses of plasminogen will be ..
- CLASSICAL AND ALTERNATIVE PATHWAYS OF FIBRINOLYSISEdward Plow; Fiscal Year: 2007..In addition, modulators of the LBS of plasminogen, apoprotein(a) and TAFI, occur naturally and their influence on plasminogen-dependent inflammatory responses of plasminogen will be ..
- Clotting genetic variant, hormones and venous thrombosisNicholas Smith; Fiscal Year: 2007..protein C, endothelial protein C receptor, protein S, antithrombin III, tissue activatable fibrinolysis inhibitor (TAFI), tissue plasminogen activator (TPA), and factors VIII, IX, X, and XlII A and B...
- EPCR, TAFI as Regulators of PMN/Endothelial InteractionFlorea Lupu; Fiscal Year: 2009..studies focus on the role of endothelial protein C receptor (EPCR) and thrombin activatable fibrinolytic inhibitor (TAFI) as regulators of the neutrophil/endothelial interaction induced by E. coli...
- MECHANISMS OF MICROVASULAR THROMBOSIS IN BABOONSFletcher Taylor; Fiscal Year: 2002..Coli) models of DIC. TAFI, the newest member of fibrinolytic inhibitors which are connected to the protein C network, also is unique in that, ..
- Genetic Analysis of Idiopathic ThrombosisLaura A Almasy; Fiscal Year: 2010..XII linkage on chromosome 10, by assessing association with a gene-centric panel of SNPs;2) to determine whether CPB2 is the previously detected QTL on chromosome 13 influencing levels of thrombin-activatable fibrinolysis inhibitor (..
- Genetic Analysis of Idiopathic ThrombosisLaura Almasy; Fiscal Year: 2009..XII linkage on chromosome 10, by assessing association with a gene-centric panel of SNPs; 2) to determine whether CPB2 is the previously detected QTL on chromosome 13 influencing levels of thrombin-activatable fibrinolysis inhibitor (..
- Genetic Analysis of Idiopathic ThrombosisLaura Almasy; Fiscal Year: 2007..XII linkage on chromosome 10, by assessing association with a gene-centric panel of SNPs; 2) to determine whether CPB2 is the previously detected QTL on chromosome 13 influencing levels of thrombin-activatable fibrinolysis inhibitor (..
- EPIDEMIOLOGY OF VENOUS THROMBOSIS AND PULMONARY EMBOLISMAaron Folsom; Fiscal Year: 2006..measure analytes found to be important in LITE already (factor V Leiden, prothrombin G20210A variant, D-dimer, and TAFI), to serve as covariates in combined analyses. 2...
- EPIDEMIOLOGY OF VENOUS THROMBOSIS AND PULMONARY EMBOLISMAaron Folsom; Fiscal Year: 2003..measure analytes found to be important in LITE already (factor V Leiden, prothrombin G20210A variant, D-dimer, and TAFI), to serve as covariates in combined analyses. 2...
- Obesity, Inflammation and Thrombosis: LOOK AHEADChristie Ballantyne; Fiscal Year: 2009..adiponectin isoforms) adipocytokines and parameters of impaired coagulant balance (PAI-1, fibrinogen, D-dimer, TAFI) in 50% of patients enrolled in the Look AHEAD trial and how this relationship is influenced by dietary intake, ..
- Obesity, Inflammation and Thrombosis: LOOK AHEADChristie M Ballantyne; Fiscal Year: 2010..adiponectin isoforms) adipocytokines and parameters of impaired coagulant balance (PAI-1, fibrinogen, D-dimer, TAFI) in 50% of patients enrolled in the Look AHEAD trial and how this relationship is influenced by dietary intake, ..
- Obesity, Inflammation and Thrombosis: LOOK AHEADChristie Ballantyne; Fiscal Year: 2007..adiponectin isoforms) adipocytokines and parameters of impaired coagulant balance (PAI-1, fibrinogen, D-dimer, TAFI) in 50% of patients enrolled in the Look AHEAD trial and how this relationship is influenced by dietary intake, ..
- FUNCTIONAL MAPPING AND PROTEIN ENGINEERING OF THROMBINLawrence Leung; Fiscal Year: 2007..b>TAFI is a latent plasma carboxypeptidase, which is activated by the thrombin-thrombomodulin (TM) complex on endothelial ..
- Cross-talk Between Coagulation, Inflammation, and ImmunityLawrence L Leung; Fiscal Year: 2010Based on studies with the pCPB KO mice, we have obtained compelling data to support our general hypothesis that thrombin-activatable carboxypeptidase B (CPB or TAFIa) plays a broad anti-inflammatory role in vivo;the targets for CPB ..
- The Role of Carboxypeptidase B and its Substrates in Rheumatoid ArthritisWilliam H Robinson; Fiscal Year: 2010..Genetic association studies using tag single nuclear polymorphisms (SNPs) representing the CPB2 gene showed that the minor allele SNP rs1409433 was associated with a reduced RA disease susceptibility...
- Development of a PEM-PET-CT Breast Imaging and Biopsy DeviceRAYMOND RAYLMAN; Fiscal Year: 2009..1mm). Image reconstruction is performed with a 3D-OSEM algorithm optimized to run on an eight CPU computer system, significantly reducing image reconstruction times...
- Development of a PEM-PET-CT Breast Imaging and Biopsy DeviceRAYMOND ROBERT RAYLMAN; Fiscal Year: 2010..1mm). Image reconstruction is performed with a 3D-OSEM algorithm optimized to run on an eight CPU computer system, significantly reducing image reconstruction times...
- Comprehensive Molecular Diagnosis for Food and Waterborne EnteropathogensEric Houpt; Fiscal Year: 2007..extraction procedures amidst the complex mixture of stool to increase sensitivity towards the goal of culture (100 CPU bacteria/g)...
- Basal ganglia modulation of trigeminal intralaminar nuclei thalamic activityEric Chudler; Fiscal Year: 2007..The first specific aim is to analyze the connectivity between the caudate- putamen (CPu) and intralaminar nuclei of the thalamus by testing the effects of electrical CPu stimulation on the responsiveness ..
- EM-TRANSMITTER INTERACTIONS OF STRIATAL OPIOID NEURONSVIRGINIA PICKEL; Fiscal Year: 2007Glutamatergic cortical inputs to the nucleus accumbens (NAc) and caudate-putamen (CPu) control motivated behaviors directly influenced by reward and by addictive drugs that can produce long-term changes in synaptic efficacy...
